Original document(351 pages)  中文版
    This invention relates to compounds that are of formula (I) wherein A is heteroaryl and R<1> and R<2> are both cyclic residues, that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial .
Application Number
申请号		 200580002021 Application Date
申请日		 2005.01.06
Title 名称 Heteroaryl-ureas and their use as glucokinase activators
Publication Number
公开号		 1910166 Publication Date
公开日		 2007.02.07
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D277/48;C07D277/56;C07D285/12;C07D277/82;C07D241/20;C07D285/08;C07D277/60;C07D213/75;C07D233/88;C07D271/08;C07D261/14;C07D417/12;C07D417/04;C07D417/06;C07D417/14
Applicant(s) Name
申请人		 Novo Nordisk AS
Address 地址
Inventor(s) Name 发明人 Murray Anthony;Lau Jesper;Jeppesen Lone;Vedso Per;Ankersen Michael;Lundbeck Jane M.;Kristiansen Marit;Valcarce-lopez Maria C.;Polisetti Dharma R.;Subramanian Govindan;Andrews Robert C.;Christen Daniel P.;Cooper Jeremy T.;Santhosh Kalpathy C.
Attorney & Agent 代理人 liu xiaodong
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.